Lensar (LNSR) Cost of Revenue (2019 - 2026)
Lensar (LNSR) reported Cost of Revenue of $7.0 million for Q1 2026, little changed year-over-year from $7.0 million in Q1 2025, and down 22.47% on a QoQ basis from $9.1 million in Q4 2025.
Lensar (LNSR) has 8 years of Cost of Revenue data on file, last reported at $7.0 million in Q1 2026.
- Quarterly Cost of Revenue changed 0.17% year-over-year to $7.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $31.3 million (up 5.28% YoY) and the FY2025 annual result came in at $31.3 million, up 13.28% from the prior year.
- Cost of Revenue fell to $7.0 million in Q1 2026 per LNSR's latest filing, from $9.1 million in the prior quarter.
- Across five years, Cost of Revenue topped out at $9.6 million in Q4 2024 and bottomed at $3.1 million in Q2 2022.
- The 5-year median for Cost of Revenue is $5.8 million (2024), against an average of $6.0 million.
- The widest annual swing landed in 2022, when Cost of Revenue plunged 32.94%; it then soared 85.49% in 2023.
- Tracing LNSR's Cost of Revenue over 5 years: stood at $3.8 million in 2022, then soared by 85.49% to $7.0 million in 2023, then surged by 38.34% to $9.6 million in 2024, then dropped by 5.56% to $9.1 million in 2025, then declined by 22.47% to $7.0 million in 2026.
- Per Business Quant, the three latest LNSR Cost of Revenue figures stand at $7.0 million (Q1 2026), $9.1 million (Q4 2025), and $8.3 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Lensar | 69.32 Mn | 69.61 Mn | 6.38 Mn | 7.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.05 Mn |
| Mar 31, 2026 | 7.05 Mn |
| Dec 31, 2025 | 9.09 Mn |
| Dec 31, 2025 | 9.09 Mn |
| Sep 30, 2025 | 8.28 Mn |
| Sep 30, 2025 | 8.28 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Jun 30, 2025 | 6.91 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Mar 31, 2025 | 7.03 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Dec 31, 2024 | 9.62 Mn |
| Sep 30, 2024 | 7.27 Mn |
| Sep 30, 2024 | 7.27 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Jun 30, 2024 | 5.82 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Mar 31, 2024 | 4.92 Mn |
| Dec 31, 2023 | 6.96 Mn |
| Dec 31, 2023 | 6.96 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Sep 30, 2023 | 4.92 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Jun 30, 2023 | 5.25 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Mar 31, 2023 | 3.93 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Dec 31, 2022 | 3.75 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Sep 30, 2022 | 3.86 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Jun 30, 2022 | 3.15 Mn |
| Mar 31, 2022 | 4.65 Mn |
| Mar 31, 2022 | 4.65 Mn |
| Dec 31, 2021 | 5.59 Mn |
| Dec 31, 2021 | 5.59 Mn |
| Sep 30, 2021 | 4.42 Mn |
| Sep 30, 2021 | 4.42 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Jun 30, 2021 | 3.46 Mn |
| Mar 31, 2021 | 3.15 Mn |
| Mar 31, 2021 | 3.15 Mn |
| Dec 31, 2020 | 3.62 Mn |
| Dec 31, 2020 | 3.62 Mn |
| Sep 30, 2020 | 3.25 Mn |
| Sep 30, 2020 | 3.25 Mn |
| Jun 30, 2020 | 3.10 Mn |
| Jun 30, 2020 | 3.10 Mn |
| Mar 31, 2020 | 2.34 Mn |
| Mar 31, 2020 | 2.34 Mn |
| Dec 31, 2019 | 3.80 Mn |
| Dec 31, 2019 | 3.80 Mn |
| Sep 30, 2019 | 4.79 Mn |
| Sep 30, 2019 | 4.79 Mn |